Since almost 20% of patients with FA carry nonsense mutations, we tested the effect of already known TRIDs, including ataluren and amlexanox, on the restoration of nonsense-mutated FANCA and FANCF protein synthesis. This evidence concerns the gene FANCF and Friedreich ataxia.